Thomas Argoud1, Stéphanie Boutroy, Bruno Claustrat, Roland Chapurlat, Pawel Szulc. 1. INSERM Unité Mixte de Recherche 1033 (T.A., S.B., R.C., P.S.), Université de Lyon, Hôpital Edouard Herriot, 69437 Lyon, France; and INSERM Unité 846 (B.C.), Université de Lyon, Laboratoire de Hormonologie, Hôpital Cardiologique, 69500 Lyon-Bron, France.
Abstract
CONTEXT: Data on the association between bone microarchitecture assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) and sex steroids in men are scarce. OBJECTIVE: Our aim was to determine the association between serum sex steroids and bone microarchitecture assessed by HR-pQCT in men. DESIGN: This is a cross-sectional analysis in the Structure of the Aging Men's Bones cohort. SETTING: The cohort was recruited from the general population. PARTICIPANTS: We examined 1169 male volunteers aged 20-87 years. No specific exclusion criteria were used. INTERVENTIONS: We collected blood samples and performed HR-pQCT at the distal radius and distal tibia. MAIN OUTCOME MEASURES: We tested the hypothesis that low sex steroid levels are associated with poor bone microarchitecture in men. RESULTS: Men aged younger than 65 years with bioavailable 17β-estradiol (bio-17β-E2) levels of14.4 pmol/L or less had higher cross-sectional and trabecular areas vs men with bio-17β-E2 greater than 14.4 pmol/L. In men aged 65 years or older, the higher the apparent free T concentration (AFTC), the higher was the distal tibia cortical density (P < .05). Cortical density and thickness as well as total and trabecular density increased with higher bio-17β-E2 levels. Similar results were found after adjustment for limb length and body height. Men with low AFTC and low bio-17β-E2 levels had lower cortical density and thickness at both skeletal sites compared with the reference group. In men with AFTC less than 272 pmol/L, those with low bio-17β-E2 less than 25 pmol/L had lower cortical density and thickness at both skeletal sites vs men having higher bio-17β-E2 levels. CONCLUSION: In men aged 65 years and older, low bio-17β-E2 levels were associated with poor cortical bone status and, to smaller extent, lower trabecular density.
CONTEXT: Data on the association between bone microarchitecture assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) and sex steroids in men are scarce. OBJECTIVE: Our aim was to determine the association between serum sex steroids and bone microarchitecture assessed by HR-pQCT in men. DESIGN: This is a cross-sectional analysis in the Structure of the Aging Men's Bones cohort. SETTING: The cohort was recruited from the general population. PARTICIPANTS: We examined 1169 male volunteers aged 20-87 years. No specific exclusion criteria were used. INTERVENTIONS: We collected blood samples and performed HR-pQCT at the distal radius and distal tibia. MAIN OUTCOME MEASURES: We tested the hypothesis that low sex steroid levels are associated with poor bone microarchitecture in men. RESULTS:Men aged younger than 65 years with bioavailable 17β-estradiol (bio-17β-E2) levels of14.4 pmol/L or less had higher cross-sectional and trabecular areas vs men with bio-17β-E2 greater than 14.4 pmol/L. In men aged 65 years or older, the higher the apparent free T concentration (AFTC), the higher was the distal tibia cortical density (P < .05). Cortical density and thickness as well as total and trabecular density increased with higher bio-17β-E2 levels. Similar results were found after adjustment for limb length and body height. Men with low AFTC and low bio-17β-E2 levels had lower cortical density and thickness at both skeletal sites compared with the reference group. In men with AFTC less than 272 pmol/L, those with low bio-17β-E2 less than 25 pmol/L had lower cortical density and thickness at both skeletal sites vs men having higher bio-17β-E2 levels. CONCLUSION: In men aged 65 years and older, low bio-17β-E2 levels were associated with poor cortical bone status and, to smaller extent, lower trabecular density.
Authors: Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas Journal: Physiol Rev Date: 2017-01 Impact factor: 37.312
Authors: S C Bilha; D Branisteanu; C Buzduga; D Constantinescu; P Cianga; E Anisie; A Covic; M C Ungureanu Journal: J Endocrinol Invest Date: 2018-01-16 Impact factor: 4.256
Authors: Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson Journal: Endocr Rev Date: 2014-09-09 Impact factor: 19.871
Authors: J P Dias; D Melvin; E M Simonsick; O Carlson; M D Shardell; L Ferrucci; C W Chia; S Basaria; J M Egan Journal: Andrology Date: 2015-11-20 Impact factor: 3.842